Cargando…
Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
Our goal in this work was to illustrate the Epstein-Barr virus (EBV)-modulated global biochemical profile and provide a novel metabolism-related target to improve the therapeutic regimen of nasopharyngeal carcinoma (NPC). We used a metabolomics approach to investigate EBV-modulated metabolic changes...
Autores principales: | Xiao, L, Hu, Z-y, Dong, X, Tan, Z, Li, W, Tang, M, Chen, L, Yang, L, Tao, Y, Jiang, Y, Li, J, Yi, B, Li, B, Fan, S, You, S, Deng, X, Hu, F, Feng, L, Bode, A M, Dong, Z, Sun, L-q, Cao, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162460/ https://www.ncbi.nlm.nih.gov/pubmed/24662831 http://dx.doi.org/10.1038/onc.2014.32 |
Ejemplares similares
-
RETRACTED ARTICLE: Cadherin 6 is activated by Epstein–Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma
por: Zuo, L-L, et al.
Publicado: (2017) -
Retraction Note: Cadherin 6 is activated by Epstein–Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma
por: Zuo, L-L, et al.
Publicado: (2022) -
Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma
por: GUO, LILI, et al.
Publicado: (2012) -
The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease
por: Selby, Thomas L., et al.
Publicado: (2019) -
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy
por: Hu, Jianmin, et al.
Publicado: (2020)